» Articles » PMID: 34321844

Human Immune Repertoire in Hepatitis B Virus Infection

Overview
Specialty Gastroenterology
Date 2021 Jul 29
PMID 34321844
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis B virus (HBV) infection is a public health threat that affects 257 million people worldwide and can progress to liver cirrhosis, liver failure, and hepatocellular carcinoma. The HBV antigen- induced adaptive immune response plays an important role in HBV clearance. Immune repertoire sequencing (IRS) has been used to investigate the molecular mechanisms behind the immune system, find novel ways to treat HBV infection, and evaluate the genetic responses and immune characteristics of individuals infected by HBV or immunized by HBV vaccine. This review summarizes the human immune repertoire analysis methodology, and the application of the IRS in the prediction of HBV infection progression, treatment, and vaccination.

Citing Articles

Deciphering Autoimmune Diseases: Unveiling the Diagnostic, Therapeutic, and Prognostic Potential of Immune Repertoire Sequencing.

Hu Y, Huang J, Wang S, Sun X, Wang X, Yu H Inflammation. 2024; .

PMID: 38914737 DOI: 10.1007/s10753-024-02079-2.


Sulforaphane effectively inhibits HBV by altering Treg/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo.

Xu R, Wu Y, Xiang X, Lv X, He M, Xu C Virus Res. 2024; 341:199316.

PMID: 38215982 PMC: 10825640. DOI: 10.1016/j.virusres.2024.199316.


T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer.

Mazzotti L, Gaimari A, Bravaccini S, Maltoni R, Cerchione C, Juan M Int J Mol Sci. 2022; 23(15).

PMID: 35955721 PMC: 9369427. DOI: 10.3390/ijms23158590.


T-Cell Receptor β Chain and B-Cell Receptor Repertoires in Chronic Hepatitis B Patients with Coexisting HBsAg and Anti-HBs.

Zhan Q, Chang L, Wu J, Zhang Z, Xu J, Yu Y Pathogens. 2022; 11(7).

PMID: 35889974 PMC: 9318409. DOI: 10.3390/pathogens11070727.


Characterization of the TCR β Chain Repertoire in Peripheral Blood from Hepatitis B Vaccine Responders and Non-Responders.

Yang J, Li Y, Ye J, Wang J, Lu H, Yao X J Inflamm Res. 2022; 15:939-951.

PMID: 35210805 PMC: 8856041. DOI: 10.2147/JIR.S347702.


References
1.
Xibing G, Xiaojuan Y, Zhonghua L, Juanhua W . Alteration in cellular immunity after chronic hepatitis B deteriorated into severe hepatitis and its significance. Hepat Mon. 2012; 11(10):810-5. PMC: 3234581. DOI: 10.5812/kowsar.1735-143x.760. View

2.
Gauss G, Lieber M . Mechanistic constraints on diversity in human V(D)J recombination. Mol Cell Biol. 1996; 16(1):258-69. PMC: 230999. DOI: 10.1128/MCB.16.1.258. View

3.
Yan Z, Zhou J, Zhang M, Fu X, Wu Y, Wang Y . Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA. Mol Med Rep. 2014; 9(5):2024-30. DOI: 10.3892/mmr.2014.2042. View

4.
Shen C, Yan W, Zhao C, Che H, Liu X, Liu Z . Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients. J Microbiol Immunol Infect. 2014; 48(2):137-46. DOI: 10.1016/j.jmii.2013.11.001. View

5.
Liu X, Wu J . History, applications, and challenges of immune repertoire research. Cell Biol Toxicol. 2018; 34(6):441-457. DOI: 10.1007/s10565-018-9426-0. View